[go: up one dir, main page]

ES557660A0 - Un procedimiento para preparar derivados de oxotiazolidina. - Google Patents

Un procedimiento para preparar derivados de oxotiazolidina.

Info

Publication number
ES557660A0
ES557660A0 ES557660A ES557660A ES557660A0 ES 557660 A0 ES557660 A0 ES 557660A0 ES 557660 A ES557660 A ES 557660A ES 557660 A ES557660 A ES 557660A ES 557660 A0 ES557660 A0 ES 557660A0
Authority
ES
Spain
Prior art keywords
alkyl
sup
compound
alkylcarbamoyl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES557660A
Other languages
English (en)
Other versions
ES8802503A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of ES8802503A1 publication Critical patent/ES8802503A1/es
Publication of ES557660A0 publication Critical patent/ES557660A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Lubricants (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
ES557660A 1985-05-14 1987-08-13 Un procedimiento para preparar derivados de oxotiazolidina. Expired ES8802503A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858512163A GB8512163D0 (en) 1985-05-14 1985-05-14 Oxothiazolidine compound

Publications (2)

Publication Number Publication Date
ES8802503A1 ES8802503A1 (es) 1988-07-16
ES557660A0 true ES557660A0 (es) 1988-07-16

Family

ID=10579098

Family Applications (2)

Application Number Title Priority Date Filing Date
ES554901A Expired ES8800185A1 (es) 1985-05-14 1986-05-13 Un procedimiento para preparar derivados de oxotiazolidina
ES557660A Expired ES8802503A1 (es) 1985-05-14 1987-08-13 Un procedimiento para preparar derivados de oxotiazolidina.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES554901A Expired ES8800185A1 (es) 1985-05-14 1986-05-13 Un procedimiento para preparar derivados de oxotiazolidina

Country Status (18)

Country Link
US (1) US4764514A (es)
EP (1) EP0203743B1 (es)
JP (1) JPS61267562A (es)
KR (1) KR860009009A (es)
AT (1) ATE60762T1 (es)
AU (1) AU593247B2 (es)
CA (1) CA1274515A (es)
DE (1) DE3677413D1 (es)
DK (1) DK222386A (es)
ES (2) ES8800185A1 (es)
FI (1) FI861935A7 (es)
GB (1) GB8512163D0 (es)
GR (1) GR861243B (es)
HU (1) HU195200B (es)
IL (1) IL78750A (es)
NO (1) NO861907L (es)
SU (2) SU1545941A3 (es)
ZA (1) ZA863285B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0755937B2 (ja) * 1986-07-29 1995-06-14 日本曹達株式会社 オキサ（チア）ゾリジン誘導体その製造方法及び殺ダニ剤
CA1322199C (en) * 1987-07-15 1993-09-14 Masami Eigyo N-¬(2-oxopyrrolidin-1-yl) acetyl)| piperazine derivatives and drug for senile dementia
EP0316723B1 (en) * 1987-11-20 1992-09-30 Hoechst-Roussel Pharmaceuticals Incorporated 3-[4(1-Substituted-4-piperazinyl)butyl]-4-thiazolidinones a process for their preparation and their use as medicaments
US5066665A (en) * 1990-05-21 1991-11-19 Warner-Lambert Co. Substituted isoxazolidin-3-ones and derivatives thereof acting at muscarinic receptors
DE4404848A1 (de) * 1994-02-16 1995-08-17 Hoechst Ag Substituierte Cyclohexanolester, ihre Verwendung zur Behandlung von Krankheiten und pharmazeutische Präparate
ES2180638T3 (es) 1994-06-03 2003-02-16 Wyeth John & Brother Ltd Nuevos procedimientos e intermediarios para la preparacion de derivados de piperazina.
CA2200055A1 (en) * 1994-09-16 1996-03-21 Novo Nordisk A/S [1,2,4]triazolo[4,3-a]quinoxalinone derivatives, their preparation and use
US5596011A (en) * 1995-04-06 1997-01-21 Repine; Karen M. Method for the treatment of macular degeneration
US6359134B1 (en) 1997-05-30 2002-03-19 Takeda Chemical Industries, Ltd. Sulfonamide derivatives, their production and use
AU2298899A (en) 1998-02-05 1999-08-23 Takeda Chemical Industries Ltd. Sulfonamide derivatives, process for producing the same and utilization thereof
US6710061B2 (en) 2001-03-09 2004-03-23 Ortho-Mcneil Pharamceutical, Inc. Aminopyrrolidine sulfonamides as serine protease inhibitors
EP1385822A1 (en) 2001-03-09 2004-02-04 Ortho-McNeil Pharmaceutical, Inc. Aminopyrrolidine sulfonamides as serine protease inhibitors
US7208497B2 (en) 2001-07-02 2007-04-24 Novo Nordisk A/S Substituted piperazines and diazepanes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3309377A (en) * 1964-10-19 1967-03-14 Sterling Drug Inc 3-[(2-oxazolidinone-3-yl)-alkyl]-4-thiazolidinones and their preparation
IT1194793B (it) * 1981-05-12 1988-09-28 Corvi Camillo Spa Derivati tiazolidinici ad attivita' farmacologica,procedimento per la loro preparazione e composizioni farmaceutiche contenenti detti derivati
DE3315424A1 (de) * 1983-04-28 1984-12-20 Cassella Ag, 6000 Frankfurt Substituierte piperazin-1-yl-essigsaeure-amide, verfahren zu ihrer herstellung und ihre verwendung
FR2552762B1 (fr) * 1983-09-30 1986-07-25 Delalande Sa Nouveaux amides piperaziniques et homopiperaziniques derives de l'acide 3,4-dioxymethylene cinnamique, leur procede de preparation et leur application en therapeutique
IL79648A (en) * 1985-08-09 1991-12-12 Lilly Co Eli Pharmaceutical anti-inflammatory and ischemia preventing compositions containing di-t-butylphenol derivatives,some such novel compounds and process for their preparation

Also Published As

Publication number Publication date
KR860009009A (ko) 1986-12-19
IL78750A (en) 1990-12-23
AU593247B2 (en) 1990-02-08
US4764514A (en) 1988-08-16
IL78750A0 (en) 1986-08-31
NO861907L (no) 1986-11-17
AU5727686A (en) 1986-11-20
ES8802503A1 (es) 1988-07-16
SU1545941A3 (ru) 1990-02-23
ES8800185A1 (es) 1987-11-01
HU195200B (en) 1988-04-28
JPH0455431B2 (es) 1992-09-03
GB8512163D0 (en) 1985-06-19
SU1493107A3 (ru) 1989-07-07
JPS61267562A (ja) 1986-11-27
EP0203743A1 (en) 1986-12-03
DK222386D0 (da) 1986-05-13
DK222386A (da) 1986-11-15
ES554901A0 (es) 1987-11-01
FI861935A0 (fi) 1986-05-09
ATE60762T1 (de) 1991-02-15
EP0203743B1 (en) 1991-02-06
CA1274515A (en) 1990-09-25
DE3677413D1 (de) 1991-03-14
FI861935A7 (fi) 1986-11-15
GR861243B (en) 1986-08-28
HUT41014A (en) 1987-03-30
ZA863285B (en) 1986-12-30

Similar Documents

Publication Publication Date Title
IL93050A0 (en) Pyrazolopyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL107426A0 (en) Heterocyclic compounds, processes for the preparation thereof, and pharmaceutical compositions containing the same
IL98872A0 (en) Pyrazolopyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
ES557660A0 (es) Un procedimiento para preparar derivados de oxotiazolidina.
IL74031A0 (en) Cyanoguanidinophenyldihydropyridazinone derivatives,their preparation and pharmaceutical compositions containing them
MY103801A (en) Dideoxydidehydrocarbocyclic nucleosides
AU4536389A (en) Anti-antherosclerotic diaryl compounds
IL112098A0 (en) Sulfamate derivatives and pharmaceutical compositions containing them
GB8504072D0 (en) Cephem compounds
IL90424A0 (en) Cephem derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
GB8401093D0 (en) Cephem compounds
ES2037095T3 (es) Un procedimiento para preparar una composicion farmaceutica.
IL93594A0 (en) Pharmaceutical compositions containing an imidazopyrimidone derivative
WO1987004435A3 (en) Xanthine compounds
DK105183D0 (da) Fremgangsmade til fremstilling af 1,4-diaminocyclitolderivater
BG95629A (en) Derivatives of 10, 11, 12, 13 - tetrahytdrodesmicozine, method for preparing them, and their use as pharmaceutical preparations